FindTrial
Sign In

Effect of stratified care based on Triangle model in prevention and intervention of cirrhotic patients with hepatic encephalopathy

Effect of stratified care based on Triangle model in prevention and intervention of cirrhotic patients with hepatic encephalopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075024
Enrollment
Unknown
Registered
2023-08-23
Start date
2021-03-17
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic encephalopathy

Interventions

Control Group :Usual care
Experimental group:Usual care+ Stratified care plan

Sponsors

Second Hospital, Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
31 Years to 84 Years

Inclusion criteria

Inclusion criteria: The diagnosis was made following the Guidelines for Diagnosis and Treatment of Cirrhosis (2019); the patients were =18 years of age; informed consent was obtained, and the patients participated in the research voluntarily.

Exclusion criteria

Exclusion criteria: (1) complicated with heart, brain, lung, kidney and other serious diseases; (2) depression, senile dementia and other cognitive disorders; (3) Metabolic, toxic, intracranial infection, sedative overdose caused by mental abnormalities; (4) suffering from severe hearing or visual impairment and other inability to cooperate; (5) Incomplete medical records.

Design outcomes

Primary

MeasureTime frame
Incidence of HE;—

Secondary

MeasureTime frame
Risk scores of HE;Quality of life for patients;Liver function (ALT, TBIL, ALB) and NH3 ;Patient satisfaction ;—

Countries

China

Contacts

Public ContactLiang Luwen

Second Hospital, Chongqing Medical University

812832683@qq.com+86 186 9665 8117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026